CYP3A4 HUMANIZED MOUSE; A MODEL TO STUDY CYP3A4-MEDIATED DRUG-DRUG INTERACTION POTENTIAL

被引：0
|
作者：
Rose, Anne [1 ]
Xu, Carrie [1 ]
Johnghar, Susan [1 ]
Behnia, Kamelia [1 ]
机构：
[1] Bristol Myers Squibb Co, New York, NY 10154 USA
来源：
DRUG METABOLISM REVIEWS | 2012年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] MDR- and CYP3A4-Mediated Drug-Drug Interactions
    Pal, Dhananjay
    Mitra, Ashim K.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (03) : 323 - 339
  • [2] The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4
    Wang, Xianming
    Zhang, Xiang
    Huang, Xinhui
    Li, Yuntong
    Wu, Mengchao
    Liu, Jingfeng
    XENOBIOTICA, 2016, 46 (07) : 651 - 658
  • [3] Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 Transgenic Mouse Models To Assess the Magnitude of CYP3A4 Mediated Drug-Drug Interactions
    Ly, Justin Q.
    Messick, Kirsten
    Qin, Ann
    Takahashi, Ryan H.
    Choo, Edna F.
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1754 - 1759
  • [4] Epidemiology of CYP3A4-Mediated Clopidogrel Drug-Drug Interactions and Their Clinical Consequences
    Tirkkonen, Tuire
    Heikkila, Pekka
    Vahlberg, Tero
    Huupponen, Risto
    Laine, Kari
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (06) : 344 - 351
  • [5] Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers
    Dutreix, Catherine
    Munarini, Florence
    Lorenzo, Sebastien
    Roesel, Johannes
    Wang, Yanfeng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (06) : 1223 - 1234
  • [6] Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4
    Denisov, Ilia G.
    Grinkova, Yelena V.
    McLean, Mark A.
    Camp, Tyler
    Sligar, Stephen G.
    BIOMOLECULES, 2022, 12 (06)
  • [7] A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
    Fahmi, Odette A.
    Maurer, Tristan S.
    Kish, Mary
    Cardenas, Edwin
    Boldt, Sherri
    Nettleton, David
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (08) : 1698 - 1708
  • [8] MDR- and CYP3A4-Mediated Drug–Drug Interactions
    Dhananjay Pal
    Ashim K. Mitra
    Journal of Neuroimmune Pharmacology, 2006, 1 : 323 - 339
  • [9] Predicting the Drug-Drug Interaction Mediated by CYP3A4 Inhibition: Method Development and Performance Evaluation
    Ren, Hong-can
    Sai, Yang
    Chen, Tao
    Zhang, Chun
    Tang, Lily
    Yang, Cheng-guang
    AAPS JOURNAL, 2021, 24 (01):
  • [10] Drug-drug interaction between tamsulosin and diltiazem, a moderate CYP3A4 inhibitor
    Byeon, Ji-Yeong
    Park, Jung-In
    Jang, Choon-Gon
    Lee, Seok-Yong
    PHARMACOTHERAPY, 2012, 32 (10): : E238 - E239
12345